drugset / Trial / NCT01844648
Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients
Phase 2
Completed
30 enrolled
NeuroHealing Pharmaceuticals Inc.
Michael J. Fox Foundation for Parkinson's Research · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
To study the safety and efficacy of tropicamide 1 mg intra-oral slow dissolving muco-adhesive thin films compared to placebo to reduce hypersalivation in PD patients manifesting sialorrhea complaints.
Timeline
- Start
- 2013-04
- Primary completion
- 2015-10
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tropicamide | Small molecule | 1 mg | Other |
Indications
No indication recorded.